225 related articles for article (PubMed ID: 15923705)
1. Carrier parents of Tay Sachs disease and beta-thalassemia.
Shah B; Bhavsar R
Indian Pediatr; 2005 May; 42(5):498-9. PubMed ID: 15923705
[No Abstract] [Full Text] [Related]
2. Carrier screening for Tay-Sachs.
Ellis I
Nursing (Lond); 1991 Sep 12-25; 4(41):16-8. PubMed ID: 1945106
[No Abstract] [Full Text] [Related]
3. Assessing the potential success of cystic fibrosis carrier screening: lessons learned from Tay-Sachs disease and beta-thalassemia.
Laberge AM; Watts C; Porter K; Burke W
Public Health Genomics; 2010; 13(5):310-9. PubMed ID: 19864874
[TBL] [Abstract][Full Text] [Related]
4. Tay-Sachs disease: knowledge and attitudes of the rabbinical community.
Abuelo DN; Rosenstein J; Sheff M
R I Med J (1976); 1985 May; 68(5):225-6. PubMed ID: 3859903
[No Abstract] [Full Text] [Related]
5. Fighting tay-sachs disease.
Trevelyan J
Nurs Times; 1989 Jun 14-20; 85(24):22-3. PubMed ID: 2748385
[No Abstract] [Full Text] [Related]
6. [Biochemical, molecular and social aspects of carrier screening for Tay-Sachs disease].
Peleg L; Gazit E; Goldman B; Akstein E
Harefuah; 1995 Dec; 129(11):475-80. PubMed ID: 8846957
[No Abstract] [Full Text] [Related]
7. Tay-Sachs disease.
Gelbart M
Nurs Times; 1998 Mar 18-24; 94(11):39. PubMed ID: 9697531
[No Abstract] [Full Text] [Related]
8. Tay-Sachs disease: Part 2. Model of a fatal, preventable, metabolic, genetic disorder.
Hecht F; Anatole P; Szucs SC
Ariz Med; 1984 Oct; 41(10):661-5. PubMed ID: 6508567
[No Abstract] [Full Text] [Related]
9. The control of genetic disease by carrier screening and antenatal diagnosis: social, ethical, and medicolegal issues.
Kaback MM
Birth Defects Orig Artic Ser; 1982; 18(7):243-54. PubMed ID: 7159734
[No Abstract] [Full Text] [Related]
10. Screening for reproductive counseling: social, ethical, and medicolegal issues in the Tay-Sachs disease experience.
Kaback MM
Prog Clin Biol Res; 1982; 103 Pt B():447-59. PubMed ID: 7163239
[No Abstract] [Full Text] [Related]
11. Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools.
Mitchell JJ; Capua A; Clow C; Scriver CR
Am J Hum Genet; 1996 Oct; 59(4):793-8. PubMed ID: 8808593
[TBL] [Abstract][Full Text] [Related]
12. Screening for Tay-Sachs disease: a note of caution.
Rosner F
J Clin Ethics; 1991; 2(4):251-2. PubMed ID: 1804394
[No Abstract] [Full Text] [Related]
13. Post counselling follow-up of thalassemia in high risk communities.
Yagnik H
Indian Pediatr; 1997 Dec; 34(12):1115-8. PubMed ID: 9715558
[No Abstract] [Full Text] [Related]
14. Tay-Sachs disease in an Arab child.
Nutman J; Navon R; Nitzan M; Gadoth N
Isr J Med Sci; 1985 Jan; 21(1):77-8. PubMed ID: 3156104
[No Abstract] [Full Text] [Related]
15. Tay-Sachs disease carrier screening: follow-up of a case-finding approach.
Clarke JT; Skomorowski MA; Zuker S
Am J Med Genet; 1989 Dec; 34(4):601-5. PubMed ID: 2624277
[TBL] [Abstract][Full Text] [Related]
16. Prevention of homozygous beta thalassemia by premarital screening and prenatal diagnosis in India.
Tamhankar PM; Agarwal S; Arya V; Kumar R; Gupta UR; Agarwal SS
Prenat Diagn; 2009 Jan; 29(1):83-8. PubMed ID: 19090545
[TBL] [Abstract][Full Text] [Related]
17. Not preventing--yet, just avoiding Tay-Sachs disease.
Scriver CR
Adv Genet; 2001; 44():267-74. PubMed ID: 11596989
[No Abstract] [Full Text] [Related]
18. Dermatoglyphs in patients with beta-thalassemia major and their thalassemia carrier parents.
Dogramaci AC; Savas N; Bagriacik MA
Coll Antropol; 2009 Jun; 33(2):607-11. PubMed ID: 19662786
[TBL] [Abstract][Full Text] [Related]
19. Prevention of thalassemia in India.
Thacker N
Indian Pediatr; 2007 Sep; 44(9):647-8. PubMed ID: 17921552
[No Abstract] [Full Text] [Related]
20. Community genetics and dignity in diversity in the Quebec Network of Genetic Medicine.
Scriver CR
Community Genet; 2006; 9(3):142-52. PubMed ID: 16741343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
